EUVIMEDEUVIMED entdecken
Crossref

Electrochemical detection of agomelatine using a high-performance FeZn LDH/graphene/polyaniline nanocomposite sensor for clinical and pharmaceutical analysis

Mohammad Omaish Ansari

Microchimica Acta · 2025

DOI: 10.1007/s00604-025-07461-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, 2025. Verfasst von Mohammad Omaish Ansari. Beteiligte Einrichtung: Center of Nanotechnology, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. omaishchem@gmail.com. Hauptthemen laut MEDLINE: Nanocomposites, Graphite, Acetamides, Aniline Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: King Abdulaziz University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic monitoring of agomelatine (AG), an antidepressant with significant pharmacokinetic variability, is hindered by the complexity and cost of conventional methods. This work presents a novel electrochemical sensor employing a ternary FeZn-layered double hydroxide (LDH)/graphene/polyaniline nanocomposite for sensitive AG detection in biological and pharmaceutical samples. The synergistic properties of the nanocomposite-combining catalytic activity, high conductivity, and electrochemical stability-were confirmed through XRD, FESEM-EDS, and XPS characterization. Electrochemical analysis showed a 65% reduction in charge transfer resistance and a 21-fold increase in electroactive surface area (0.576 cm2) compared with unmodified electrodes. Using square-wave voltammetry, the sensor achieved a broad linear detection range (5-140 nM), high sensitivity (950.7 nA nM-1 cm-2), and a low detection limit. It demonstrated excellent reproducibility (< 2.5% RSD) and high recoveries (96.9-102.9%) in human urine and commercial tablets, surpassing existing nanocomposite sensors. The sensor maintained performance against 100-fold excesses of common interferents (e.g., glucose, ascorbic acid, Na+, Ca2+). By overcoming key limitations in plasma compatibility and sensitivity, this FeZn LDH/graphene/polyaniline sensor offers a robust, sustainable platform for real-time AG monitoring, directly applicable in clinical diagnostics and pharmaceutical quality control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanocompositesGraphiteAcetamidesAniline CompoundsElectrochemical TechniquesHumansLimit of DetectionZincIronHydroxidesElectrodesReproducibility of ResultsTabletsNaphthalenes

Stichwörter der Autor:innen

AgomelatineElectrochemical sensor; Square wave voltammetryFeZn LDH/graphene/PANI nanocompositeUrine analysis

Substanzen

GraphiteAcetamidesAniline CompoundspolyanilineagomelatineZincIronHydroxidesTabletsNaphthalenes

Autor:innen und Institutionen

  • Center of Nanotechnology, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. omaishchem@gmail.com.

Förderung

  • King Abdulaziz University

Zitieren

APA

Ansari, M. O. (2025). Electrochemical detection of agomelatine using a high-performance FeZn LDH/graphene/polyaniline nanocomposite sensor for clinical and pharmaceutical analysis. Microchimica Acta. https://doi.org/10.1007/s00604-025-07461-x

Vancouver

Ansari MO. Electrochemical detection of agomelatine using a high-performance FeZn LDH/graphene/polyaniline nanocomposite sensor for clinical and pharmaceutical analysis. Microchimica Acta. 2025. doi:10.1007/s00604-025-07461-x

BibTeX
@article{Ansari2025,
  author = {Ansari, Mohammad Omaish},
  title = {Electrochemical detection of agomelatine using a high-performance FeZn LDH/graphene/polyaniline nanocomposite sensor for clinical and pharmaceutical analysis},
  journal = {Microchimica Acta},
  year = {2025},
  doi = {10.1007/s00604-025-07461-x}
}
Kostenlos starten →